Showing results (141-150 of 194) with videos related to

Sort By:
Pageof 20
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 9, 2014
Hemodynamic effects of left atrial or left ventricular cannulation for acute circulatory support in a bovine model of left heart injuryNavin K Kapur, Vikram Paruchuri, Duc Thinh Pham, et al.
International Journal of Radiation Oncology, Biology, Physics|August 3, 2026
Long-Term Outcomes of Advanced Pneumatic Compression Device vs. Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical TrialSheila H Ridner, Derek K Smith, Cristina M Kline-Quiroz, et al.
JCI Insight|July 8, 2020
Key driver genes as potential therapeutic targets in renal allograft rejectionZhengzi Yi, Karen L Keung, Li Li, et al.
Clinical Transplantation|June 13, 2012
Effect of high-dose intravenous immunoglobulin on anti-HLA antibodies in sensitized kidney transplant candidatesVinay Nair, Deirdre Sawinski, Enver Akalin, et al.
Trials|January 12, 2021
Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partnersPenelope Schofield, Karla Gough, Amelia Hyatt, et al.
Head & Neck|January 23, 2026
Short-Term Outcomes of Advanced Pneumatic Compression Device Versus Usual Care Therapy for Head and Neck Cancer-Related Lymphedema: A Multi-Site Randomized Clinical TrialBarbara A Murphy, Derek K Smith, Cristina M Kline-Quiroz, et al.
Scientific Reports|January 5, 2017
Novel Therapeutics Identification for Fibrosis in Renal Allograft Using Integrative Informatics ApproachLi Li, Ilana Greene, Benjamin Readhead, et al.
Kidney International|October 3, 2017
Analysis of OPTN/UNOS registry suggests the number of HLA matches and not mismatches is a stronger independent predictor of kidney transplant survivalRabi Yacoub, Girish N Nadkarni, Paolo Cravedi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1Anthony W Tolcher, John Sarantopoulos, Amita Patnaik, et al.
Oral Oncology|January 17, 2015
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinomaJill Gilbert, Michael J Schell, Xiuhua Zhao, et al.
Pageof 20